The EVERY Co Raises $55M to Scale Egg Proteins
The EVERY Co, a company that uses precision fermentation to make egg proteins with microbes, has raised $55 million in its Series D round.
Most buyers are motivated by basic economics
The funding, led by McWin Capital Partners, will help the company expand its manufacturing capacity and move towards profitability. The EVERY Co's products featuring its proteins are set to launch at Walmart across the US.
- Cumulative funding: $294 million
- Investors: McWin Capital Partners, Main Sequence, Bloom8, TO.VC, Minerva Foods, Grosvenor Food & AgTech, New Agrarian, and SOSV
Founder and CEO Arturo Elizondo stated that the company had initially aimed to raise $50 million but ended up closing in on $55 million, with a second close planned for later this year.
Author's summary: The EVERY Co raises $55 million to scale egg proteins via fermentation, expanding its manufacturing capacity.